title: Absolute risk reduction may depend on the duration of the follow-up.
abstract: Response to: Diamond DA and Ravnskov U. How statistical deception created the appearance that statins are safe and effective in primary and secondary prevention of cardiovascular disease. Expert Rev Clin Pharm 2015;8(2):201-210.
authors.affiliation: a John von Neumann Faculty of Informatics, Physiological Controls Group , Óbuda University , Budapest , Hungary.
authors.forename: Tamás
authors.identifier: 0000-0001-6791-3080
authors.initials: T
authors.lastname: Ferenci
mesh_terms: D002318:Cardiovascular Diseases; D008192:Deception; D005500:Follow-Up Studies; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D061366:Numbers Needed To Treat; D055502:Secondary Prevention
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors